Matthew Licause
Family Medicine · North Canton, OHNPI 1205890019
Payments from drug & device makers
Across 149 payments — averaging $14.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$351
- Novo Nordisk$343
- Boehringer Ingelheim$220
- AstraZeneca$173
- Merck$152
- Amgen$130
- plus $754 from 17 others
What the payments were for
- Food & beverage$1,97693%
- Education$1467%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 23 | $351 |
| Novo Nordisk | 25 | $343 |
| Boehringer Ingelheim | 18 | $220 |
| AstraZeneca | 10 | $173 |
| Merck | 14 | $152 |
| Amgen | 9 | $130 |
| Lilly USA, LLC | 8 | $129 |
| AbbVie(2 entities) | 5 | $71 |
| Radius Health, Inc. | 4 | $71 |
| Amarin Pharma, Inc. | 4 | $60 |
| Astellas Pharma US Inc | 4 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $54 |
| Abbott | 3 | $53 |
| Exact Sciences | 2 | $42 |
| Novartis | 3 | $41 |
| GSK | 3 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Arbor Pharmaceuticals, Inc. | 2 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Mayne Pharma Commercial LLC | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EUCRISA$140
How this compares
$2,122 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 28 | $24,035 |
| JanuviaSitagliptin Phosphate | 11 | $15,021 |
| JardianceEmpagliflozin | 16 | $11,899 |
| Atorvastatin Calcium | 153 | $1,741 |
| Metoprolol Succinate | 66 | $931 |
| Losartan Potassium | 102 | $925 |
| Valsartan | 14 | $798 |
| Pantoprazole Sodium | 72 | $764 |
| Levothyroxine Sodium | 71 | $733 |
| Rosuvastatin Calcium | 58 | $725 |
| ClopidogrelClopidogrel Bisulfate | 42 | $567 |
| Lisinopril | 83 | $564 |
| Simvastatin | 59 | $499 |
| Omeprazole | 29 | $488 |
| Amlodipine Besylate | 113 | $485 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $351 | $24,03528 claims |
| MerckJanuvia | $152 | $15,02111 claims |
| Boehringer IngelheimJardiance | $220 | $11,89916 claims |
| AbbVieSynthroid | $71 | $39511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in North Canton
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.